Publication Name	World Journal of Hematology
Manuscript ID	22838
Country	Australia

Received	2015-09-28 08:43
Peer-Review Started	2015-10-03 21:13
To Make the First Decision	2015-10-27 10:48
Return for Revision	2015-10-30 10:14
Revised	2015-11-17 21:45
Second Decision	2015-12-07 09:35
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2015-12-14 17:59
Articles in Press	2015-12-14 17:59
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-01-20 15:27
Publish the Manuscript Online	2016-01-28 15:54

ISSN	2218-6204 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Hematology
Manuscript Type	Review
Article Title	Insights into myelodysplastic syndromes from current preclinical models
Manuscript Source	Invited Manuscript
All Author List	Shuh Ying Tan, Monique F Smeets, Alistair M Chalk, Harshal Nandurkar, Carl R Walkley, Louise E Purton and Meaghan Wall
Funding Agency and Grant Number	Funding Agency Grant Number The Leukemia Foundation Victorian State Government Operational Infrastructure Support Scheme NHMRC
Corresponding Author	Meaghan Wall, MBBS, PhD, Victorian Cancer Cytogenetics Service, St. Vincent’s Hospital, 41 Victoria Parade, Fitzroy 3065, Victoria, Australia. meaghan.wall@svha.org.au
Key Words	Myelodysplastic syndromes; Mouse models; Genetic mutations
Core Tip	Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal hematopoietic disorders. In recent years, we have witnessed a rapidly expanding catalog of MDS candidate genes. Mirroring this, there has been an increased number of candidate genes employed to model MDS. Here, we aim to review currently avai-lable mouse models of MDS, highlighting models that are robust and well-characterized phenotypically with a particular focus on models that demonstrate close resemblance to the human disease.
Publish Date	2016-01-28 15:54
Citation	Tan SY, Smeets MF, Chalk AM, Nandurkar H, Walkley CR, Purton LE, Wall M. Insights into myelodysplastic syndromes from current preclinical models. World J Hematol 2016; 5(1): 1-22
URL	http://www.wjgnet.com/2218-6204/full/v5/i1/1.htm
DOI	http://dx.doi.org/10.5315/wjh.v5.i1.1

Full Article (PDF)	WJH-5-1.pdf
Full Article (Word)	WJH-5-1.doc
Manuscript File	22838-Review.docx
Answering Reviewers	22838-Answering reviewers.pdf
Audio Core Tip	22838-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	22838-Conflict-of-interest statement.pdf
Copyright License Agreement	22838-Copyright assignment.pdf
Peer-review Report	22838-Peer-review(s).pdf
Scientific Misconduct Check	22838-Scientific misconduct check.pdf
Scientific Editor Work List	22838-Scientific editor work list.pdf